RT Journal Article
SR Electronic
T1 Statistical Analysis Plan for the Primary and Selected Secondary Endpoints in the ENHANCED-SPS Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.09.01.23294899
DO 10.1101/2023.09.01.23294899
A1 Balzer, Laura B.
A1 Kabami, Jane
A1 ,
YR 2023
UL http://medrxiv.org/content/early/2023/09/04/2023.09.01.23294899.abstract
AB This document provides the statistical analytic plan (SAP) for the ENHANCED-SPS study, a cluster randomized trial to evaluate the effects of peer-led, multicomponent intervention on viral suppression and other care outcomes among pregnant and breastfeeding women with HIV in South Western Uganda (Clinicaltrials.gov: NCT04122144). The SAP was locked prior to unblinding and effect estimation. This SAP was embargoed until August 31, 2023 when it was submitted to medRxiv.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04122144Funding StatementMak-ImS program (FIC NIH Award Number: D43TW010037, 2 D43TW010037)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:School of Medicine Research and Ethics Committee (SOMREC) of Makerere University (Uganda) and the Uganda National Council for Science and Technology (UNCST) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesNot applicable